knowledge -WSS

knowledge

author：explore 2025-10-01 12:35:51 - browse：1

Adobe

The Food and Drug Administration is expected to approve Merck’s drug to treat a rare lung disorder called pulmonary arterial hypertension on Tuesday, making available a novel treatment for a deadly condition that’s long been challenging to treat.

In a large trial published last year, the drug, called sotatercept, exceeded expectations in significantly increasing the distance that patients could walk and cutting the risk that their condition would worsen, that they would die, and that they would need new treatments.

Pulmonary arterial hypertension, or PAH, is estimated to occur in 15 to 50 per million people, mostly in women. It’s characterized by a proliferation of cells in the blood vessels that connect the right side of heart to the lungs, making it harder for blood to pass through and leading the heart to have to work harder to pump blood into the lungs. The disease, which causes difficulty breathing, fatigue and dizziness, has a high mortality rate, with one study finding that one-fifth of patients died at around three years after diagnosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Novo pauses ads for weight loss drug Wegovy amid demand

WSS

FDA struggles to regulate food additives, sometimes for decades

STAT Summit: Biotech founders on deal

2023 STAT Wunderkinds: get to know the winners

Living organ donors deserve priority status for transplants

Why health workers in Gaza are injured or die at high rates

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

hotspot

knowledge

entertainment

Hollywood unions extend contract negotiations for actors

STAT Summit: How a Chicago ER doctor tackles gun violence

United colonoscopy coverage change 'may cost lives,' doctors say

Can medical device makers keep up in the race to treat obesity?

Sports medicine is finally prioritizing gender equality

NIH confirmation hearing shows politicization of research

Jerome Adams on the need for new antivirals for Covid

Senate panel passes drug pricing bills, but drops one PBM reform

How one medical school became remarkably diverse

NIH confirmation hearing shows politicization of research

hotspot

Medicare reduced heart disease by changing how it pays doctors

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

The explosion of genetic testing requires a new approach

CEOs share strategies for surviving biotech slump

STAT Readout Newsletter: Today's biggest biotech updates

Altering the blood type of lungs raises potential for universal organs for transplants

hotspot

knowledge

focus

knowledge